Regaining compliance with Nasdaq's minimum bid price requirement is crucial for 60 Degrees Pharmaceuticals as it ensures the company's continued listing on the Nasdaq Capital Market. This development is likely to have a positive impact on the stock price as it removes the risk of delisting, which can be a significant concern for investors.